Evaluation of tissue-engineered skin (Human Skin Substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery

Dermatologic Surgery

Volumn 28, Issue 12, 2002, Pages 1107-1114

  Gohari, Sharon ^a   Gambla, Charles ^a   Healey, Mary ^a   Spaulding, Gail ^a   Gordon, Kenneth B ^a   Swan, James ^a   Cook, Brian ^a   West, Dennis P ^a   Lapiere, Jean Christophe ^a   Siegel, Daniel ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHEMOSURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; EPITHELIZATION; ERYTHEMA; EVALUATION; EXCISION; EXUDATE; HEMATOMA; HUMAN; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SKIN INFECTION; SKIN INJURY; TISSUE ENGINEERING; VISUAL ANALOG SCALE; WOUND DRESSING; WOUND HEALING;

EID: 0036950647     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200212000-00003     Document Type: Article

References (38)

1. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 1975;6:331-4.
2. Odyssey R. Multicenter experience with cultured autografts for treatment of burns. J Burn Care Rehabil 1992;13:174-80.
3. Phillips TJ, Kehinde O, Green H, Gilchrest BA. Treatment of skin ulcers with epidermal allografts. J Am Acad Dermatol 1989;21:191-9.
4. Teepe RGC, Koebrugge EJ, Ponec M, Vermeer BJ. Fresh versus cryopreserved allografts for the treatment of chronic skin ulcers. Br J Dermatol 1990;122:81-9.
5. Leigh IM, Purkis PE, Navsaria HA, Phillips TJ. Treatment of chronic venous ulcers with sheets of cultured allogeneic keratinocytes. Br J Dermatol 1987;117:591-7.
6. Kolenik SA III, Leffell DJ. The use of cryopreserved human skin allografts in wound healing following Mohs surgery. Dermatol Surg 1995;21:615-20.
7. Lamme EN, Van Leeuwan RT, Brandsma K, Van Marie J, Middelkoop E. Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation. J Pathol 2000;190:595-603.
8. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999;341:738-45.
9. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981;211:1052-4.
10. Bell E, Rosenberg M, Kemp P, et al. Recipes for reconstituting skin. J Biomech Eng 1991;113:113-9.
11. Falanga V, Margolis D, Alvarez O, et al. and the Human Skin Equivalent Investigators Group. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 1998;134:293-300.
12. Falabella AF, Schachner LA, Valencia IC, Eaglstein WH. The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol 1999;135:1219-22.
13. Horn WA. HSS heals an ulcer on an amputation stump. Dermatol Surg 2000;26:946-8.
14. Brem H, Balledux J, Bloom T, Kerstein MD, Holler L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing. Arch Surg 2000;135:627-34.
15. Flores F, Eaglstein WH, Kirsner RS. Hydroxyurea-induced leg ulcers treated with Apligraf. Ann Intern Med 2000;132:417-8.
16. Waymack P, Duff RG, Sabolinski M, and the Apligraf Burn Study Group. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. Burns 2000;26:609-19.
17. Loss M, Wedler V, Kunzie W, Meuli-Simmen C, Meyer VE. Artificial skin, split-thickness autograft and cultured autologous keratinocytes combined to treat a severe burn injury of 93% of TBSA. Burns 2000;26:644-52.
18. Chang DW, Sanchez LA, et al. Can a tissue-engineered skin graft improve healing of lower extremity foot wounds after revascularization? Ann Vasc Surg 2000;14:44-9.
19. De Imus G, Golomb C, et al. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 2001;44:61-6.
20. Eaglstein WH, Alvarez OM, Auletta M, et al. Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol Surg 1999;25:195-201.
21. Eaglstein WH, Iriondo M, Laszlo K. A composite skin substitute (HSS) for surgical wounds: A clinical experience. Dermatol Surg 1995;21:839-43.
22. Muhart M, Mcfalls S, Kirsner RS, et al. Behavior of tissue-engineered skin: A comparison of a living skin equivalent (LSE), autograft, and an occlusive dressing on human donor sites. Arch Dermatol 1999;135:913-8.
23. Sullivan T, Smith J, Kermode J, McIver E, Courtmanche DJ. Rating the burn scar. J Burn Care Rehab 1990;11:256-60.
24. Rosenberg AS, Weatherly B. Rose, et al. Antigen specific effector mechanisms in skin allografts rejection. Transplant Proc 1989;21:131-2.
25. Nickoloff BJ, Turka LA, Mitra RS, Nestle FO. Direct and indirect control of T-cell activation by keratinocytes. J Invest Dermatol 1995;105:25S-29S.
26. Theobald VA, Lauer JD, Kaplan FA, Baker KB, Rosenberg M. Neutral allografts, lack of allogeneic stimulation by cultured human cells expressing MHC class I and class II antigens. Transplantation 1993;55:128-33.
27. Miller EJ. The structure of fibril-forming collagens. In: Fleischmajet, R, Olsen, BR, Kuhn, K, eds. Biology, Chemistry, and Pathology of Collagen. New York, NY: New York Academy of Sciences; 1985:1-13.
28. Thivolet J, Faure M, Demidem A, et al. Long term survival and Immunological tolerance of human epidermal allografts produced in culture. Transplantation 1986;42:274-80.
29. Brain A, Purkis P, Coates P, et al. Survival of cultured allogenic keratinocytes transplanted to deep dermal bed assessed with probe specific for Y chromosome. BMJ 1989;298:917-9.
30. Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a smart material for healing wounds: Experience in venous ulcers. Biomaterials 1996;17:311-20.
31. Goretsky MJ, Harriger MD (Suppl. AP), Greenhalgh DG, Boyce ST. Expression of interteukin-α, interleukin-6, and basic fibroblast growth factor by cultured skin substitutes before and after grafting to full-thickness wounds in athymic mice. J Trauma-Injury Infection Crit Care 1996;40:894-9.
32. Le Poole IC, Boyce ST. Keratinocytes suppress transforming growth factor-beta1 expression by fibroblasts in cultured skin substitutes. Br J Dermatol 1999;140:409-16.
33. Badiavas EV, Paquette D, Carson P, Falanga V. Human chronic wounds treated with bioengineered skin. Histologic evidence of host-graft interaction. J Am Acad Dermatol 2002;46:524-30.
34. Falanga V, Margolis D, Alvarez O, et al, and the Human Skin Equivalent Investigators Group. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 1998;134:293-300.
35. Kolenik SA, Leffell DJ. Wound healing following Mobs surgery. Dermatol Surg 1995;21:615-20.
36. Tarlow MM, Nossa R, Spencer JM. Effective management of difficult surgical defects using tissue-engineered skin. Dermatol Surg 2001;27:71-4.
37. De Imus G, Golomb C, et al. Accelerated healing of pyoderma grangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 2001;44(1):61-6.
38. Phillips TJ. New skin for old: Developments in biological skin substitutes. Arch Dermatol 1998;134:344-9.